Alprazolam 2 MG Oral Tablet — RxCUI 197322
RxNorm drug concept · Semantic clinical drug
RxCUI 197322
Semantic clinical drug · SCD
● Current RxNorm concept 52 FDA products
149 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197322
Official nameAlprazolam 2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped52
Package NDCs mapped149
Reported Medicaid activity (SDUD)2,759,873 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Alprazolam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Alprazolam is used to treat generalized anxiety disorder (GAD) and panic disorder — including panic disorder that involves a fear of being in public places (agoraphobia). Different...
- It can, especially when you first start taking it or if your dose changes. Sedation, sleepiness, and memory or concentration issues are among the most commonly reported side effect...
- Will alprazolam make me feel drowsy or foggy?
- Please don't stop on your own — this is really important. Your body can become physically dependent on alprazolam even after short-term use, and stopping suddenly can trigger serio...
🕸️ Concept Web — How Alprazolam 2 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Alprazolam 2 MG Oral Tablet
RxCUI 197322 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Alprazolam
596IN
-
Alprazolam
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xanax
202363BN
-
Xanax
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Alprazolam Oral Tablet
370548SCDF -
Alprazolam Oral Product
1155284SCDG -
Alprazolam Pill
1155285SCDG -
Alprazolam Oral Tablet [Xanax]
94610SBDF -
Xanax Oral Product
1186300SBDG -
Xanax Pill
1186301SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Alprazolam Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Alprazolam 2 MG
315317SCDC -
Alprazolam 2 MG Oral Tablet [Xanax]
214004SBD -
Alprazolam 2 MG [Xanax]
573848SBDC
-
Alprazolam 2 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Alprazolam 2 MG
SCDC · 315317 -
Alprazolam Oral Tablet
SCDF · 370548 -
Alprazolam Oral Product
SCDG · 1155284 -
Alprazolam Pill
SCDG · 1155285
Brand-Name Concepts
-
Alprazolam 2 MG Oral Tablet [Xanax]
SBD · 214004 -
Alprazolam 2 MG [Xanax]
SBDC · 573848 -
Alprazolam Oral Tablet [Xanax]
SBDF · 94610 -
Xanax Oral Product
SBDG · 1186300 -
Xanax Pill
SBDG · 1186301 -
Xanax
BN · 202363
📦 FDA Products & Package NDCs
52 products · 149 package NDCs
149 package NDCs map to RxCUI 197322 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 70954-0511-10 | 100 TABLET in 1 BOTTLE (70954-511-10) | Alprazolam | ANI Pharmaceuticals, Inc. | 2021-05-11 |
| 70954-0511-20 | 500 TABLET in 1 BOTTLE (70954-511-20) | Alprazolam | ANI Pharmaceuticals, Inc. | 2021-05-11 |
| 71335-0920-01 | 30 TABLET in 1 BOTTLE (71335-0920-1) | Alprazolam | Bryant Ranch Prepack | 2018-08-02 |
| 71335-0920-02 | 60 TABLET in 1 BOTTLE (71335-0920-2) | Alprazolam | Bryant Ranch Prepack | 2021-12-28 |
| 71335-0920-03 | 90 TABLET in 1 BOTTLE (71335-0920-3) | Alprazolam | Bryant Ranch Prepack | 2021-12-28 |
| 71335-0920-04 | 100 TABLET in 1 BOTTLE (71335-0920-4) | Alprazolam | Bryant Ranch Prepack | 2021-12-28 |
| 71335-0920-05 | 10 TABLET in 1 BOTTLE (71335-0920-5) | Alprazolam | Bryant Ranch Prepack | 2021-12-28 |
| 71335-0920-06 | 120 TABLET in 1 BOTTLE (71335-0920-6) | Alprazolam | Bryant Ranch Prepack | 2021-12-28 |
| 71335-0920-07 | 40 TABLET in 1 BOTTLE (71335-0920-7) | Alprazolam | Bryant Ranch Prepack | 2021-12-28 |
| 71335-1894-01 | 30 TABLET in 1 BOTTLE (71335-1894-1) | Alprazolam | Bryant Ranch Prepack | 2021-06-29 |
| 71335-1894-02 | 60 TABLET in 1 BOTTLE (71335-1894-2) | Alprazolam | Bryant Ranch Prepack | 2021-06-29 |
| 71335-1894-03 | 90 TABLET in 1 BOTTLE (71335-1894-3) | Alprazolam | Bryant Ranch Prepack | 2021-06-29 |
| 71335-1894-04 | 100 TABLET in 1 BOTTLE (71335-1894-4) | Alprazolam | Bryant Ranch Prepack | 2021-06-29 |
| 71335-1894-05 | 10 TABLET in 1 BOTTLE (71335-1894-5) | Alprazolam | Bryant Ranch Prepack | 2021-06-29 |
| 71335-1894-06 | 120 TABLET in 1 BOTTLE (71335-1894-6) | Alprazolam | Bryant Ranch Prepack | 2021-06-29 |
| 71335-1894-07 | 40 TABLET in 1 BOTTLE (71335-1894-7) | Alprazolam | Bryant Ranch Prepack | 2021-06-29 |
| 72189-0450-60 | 60 TABLET in 1 BOTTLE (72189-450-60) | Alprazolam | Direct_Rx | 2023-03-22 |
| 76420-0663-01 | 100 TABLET in 1 BOTTLE (76420-663-01) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0663-30 | 30 TABLET in 1 BOTTLE (76420-663-30) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0663-60 | 60 TABLET in 1 BOTTLE (76420-663-60) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0663-90 | 90 TABLET in 1 BOTTLE (76420-663-90) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0664-01 | 100 TABLET in 1 BOTTLE (76420-664-01) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0664-30 | 30 TABLET in 1 BOTTLE (76420-664-30) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0664-60 | 60 TABLET in 1 BOTTLE (76420-664-60) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0664-90 | 90 TABLET in 1 BOTTLE (76420-664-90) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0665-01 | 100 TABLET in 1 BOTTLE (76420-665-01) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0665-30 | 30 TABLET in 1 BOTTLE (76420-665-30) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0665-60 | 60 TABLET in 1 BOTTLE (76420-665-60) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0665-90 | 90 TABLET in 1 BOTTLE (76420-665-90) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0666-01 | 100 TABLET in 1 BOTTLE (76420-666-01) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0666-30 | 30 TABLET in 1 BOTTLE (76420-666-30) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0666-60 | 60 TABLET in 1 BOTTLE (76420-666-60) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 76420-0666-90 | 90 TABLET in 1 BOTTLE (76420-666-90) | Alprazolam | Asclemed USA, Inc. | 2024-01-11 |
| 87063-0171-01 | 100 TABLET in 1 BOTTLE (87063-171-01) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0171-30 | 30 TABLET in 1 BOTTLE (87063-171-30) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0171-60 | 60 TABLET in 1 BOTTLE (87063-171-60) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0171-90 | 90 TABLET in 1 BOTTLE (87063-171-90) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0172-01 | 100 TABLET in 1 BOTTLE (87063-172-01) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0172-30 | 30 TABLET in 1 BOTTLE (87063-172-30) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0172-60 | 60 TABLET in 1 BOTTLE (87063-172-60) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0172-90 | 90 TABLET in 1 BOTTLE (87063-172-90) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0173-01 | 100 TABLET in 1 BOTTLE (87063-173-01) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0173-30 | 30 TABLET in 1 BOTTLE (87063-173-30) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0173-60 | 60 TABLET in 1 BOTTLE (87063-173-60) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0173-90 | 90 TABLET in 1 BOTTLE (87063-173-90) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0174-01 | 100 TABLET in 1 BOTTLE (87063-174-01) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0174-30 | 30 TABLET in 1 BOTTLE (87063-174-30) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0174-60 | 60 TABLET in 1 BOTTLE (87063-174-60) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
| 87063-0174-90 | 90 TABLET in 1 BOTTLE (87063-174-90) | Alprazolam | ASCLEMED USA INC. | 2026-04-30 |
Observed labelers:
ASCLEMED USA INC. (16) ·
Asclemed USA, Inc. (16) ·
Bryant Ranch Prepack (14) ·
Aurobindo Pharma Limited (12) ·
Natco Pharma USA LLC (12) ·
Proficient Rx LP (12)
· +10 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.